C.H. Robinson to acquire RXO in a $5.8 billion cash‑and‑stock transaction

C.H. Robinson Worldwide announced a definitive agreement to acquire RXO Inc. in a cash‑and‑stock deal valued at $5.8 billion. RXO shareholders will receive $30.25 per share, a 29% premium to the October 2 closing price, and the combined company is expected to have an enterprise value of more than $25 billion. The transaction is slated to close in the first half of 2027, subject to shareholder and regulatory approvals, and includes a $4.5 billion bridge loan to back the cash portion.

The company says the deal should generate about $300 million of net run‑rate cost synergies within two years, which could improve earnings but also adds debt and dilution risk for shareholders (the bridge loan and premium). Analysts note the premium and integration risk may pressure CHRW’s share price in the short term.

Sources